| Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species SG Whaley, EL Berkow, JM Rybak, AT Nishimoto, KS Barker, PD Rogers Frontiers in microbiology 7, 2173, 2017 | 1066 | 2017 |
| Mechanisms of antifungal drug resistance LE Cowen, D Sanglard, SJ Howard, PD Rogers, DS Perlin Cold Spring Harbor perspectives in medicine 5 (7), a019752, 2015 | 783 | 2015 |
| Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida albicans TT Liu, REB Lee, KS Barker, RE Lee, L Wei, R Homayouni, PD Rogers Antimicrobial agents and chemotherapy 49 (6), 2226-2236, 2005 | 450 | 2005 |
| The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans J Morschhäuser, KS Barker, TT Liu, J Blaß-Warmuth, R Homayouni, ... PLoS pathogens 3 (11), e164, 2007 | 437 | 2007 |
| A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens CC Daniels, PD Rogers, CM Shelton The journal of pediatric pharmacology and therapeutics 21 (1), 27-35, 2016 | 384 | 2016 |
| Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans SA Flowers, B Colón, SG Whaley, MA Schuler, PD Rogers Antimicrobial agents and chemotherapy 59 (1), 450-460, 2015 | 361 | 2015 |
| A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida … N Dunkel, TT Liu, KS Barker, R Homayouni, J Morschhäuser, ... Eukaryotic cell 7 (7), 1180-1190, 2008 | 343 | 2008 |
| Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans … N Dunkel, J Blaß, PD Rogers, J Morschhäuser Molecular microbiology 69 (4), 827-840, 2008 | 340 | 2008 |
| Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans SA Flowers, KS Barker, EL Berkow, G Toner, SG Chadwick, SE Gygax, ... Eukaryotic cell 11 (10), 1289-1299, 2012 | 306 | 2012 |
| Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies JP Vermitsky, KD Earhart, WL Smith, R Homayouni, TD Edlind, ... Molecular microbiology 61 (3), 704-722, 2006 | 305 | 2006 |
| Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae AK Agarwal, PD Rogers, SR Baerson, MR Jacob, KS Barker, JD Cleary, ... Journal of Biological Chemistry 278 (37), 34998-35015, 2003 | 252 | 2003 |
| Resistance and cross‐resistance to imidacloprid and thiamethoxam in the Colorado potato beetle Leptinotarsa decemlineata A Alyokhin, G Dively, M Patterson, C Castaldo, D Rogers, M Mahoney, ... Pest Management Science: formerly Pesticide Science 63 (1), 32-41, 2007 | 218 | 2007 |
| Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates PD Rogers, KS Barker Antimicrobial agents and chemotherapy 47 (4), 1220-1227, 2003 | 206 | 2003 |
| An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans CJ Heilmann, S Schneider, KS Barker, PD Rogers, J Morschhäuser Antimicrobial agents and chemotherapy 54 (1), 353-359, 2010 | 193 | 2010 |
| Voriconazole: a new triazole antifungal agent MM Pearson, PD Rogers, JD Cleary, SW Chapman Annals of Pharmacotherapy 37 (3), 420-432, 2003 | 185 | 2003 |
| Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris JM Rybak, LA Doorley, AT Nishimoto, KS Barker, GE Palmer, PD Rogers Antimicrobial agents and chemotherapy 63 (4), 10.1128/aac. 00057-19, 2019 | 181 | 2019 |
| Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris JM Rybak, JF Muñoz, KS Barker, JE Parker, BD Esquivel, EL Berkow, ... MBio 11 (3), 10.1128/mbio. 00365-20, 2020 | 175 | 2020 |
| Antifungal therapy during pregnancy CT King, PD Rogers, JD Cleary, SW Chapman Clinical Infectious Diseases 27 (5), 1151-1160, 1998 | 175 | 1998 |
| Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans KS Barker, S Crisp, N Wiederhold, RE Lewis, B Bareither, J Eckstein, ... Journal of Antimicrobial Chemotherapy 54 (2), 376-385, 2004 | 171 | 2004 |
| Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans S Schubert, KS Barker, S Znaidi, S Schneider, F Dierolf, N Dunkel, M Aïd, ... Antimicrobial agents and chemotherapy 55 (5), 2212-2223, 2011 | 163 | 2011 |
Jeffrey M. Rybak, Pharm.D., Ph.D.St. Jude Children’s Research HospitalVerified email at stjude.org
